Scancell (LON:SCLP) Stock Price Passes Below 50 Day Moving Average – Time to Sell?

Scancell Holdings plc (LON:SCLP)’s share price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 12.61 and traded as low as GBX 11. Scancell shares last traded at GBX 11.50, with a volume of 771,796 shares changing hands.

Scancell Stock Down 0.1%

The company has a market capitalization of £116.65 million, a P/E ratio of -20.44 and a beta of 0.33. The company has a debt-to-equity ratio of -193.29, a quick ratio of 13.01 and a current ratio of 0.56. The firm’s fifty day moving average is GBX 12.61 and its 200-day moving average is GBX 11.05.

Scancell (LON:SCLP) last announced its quarterly earnings results on Thursday, January 29th. The company reported GBX (0.55) earnings per share (EPS) for the quarter. Scancell had a negative net margin of 116.98% and a positive return on equity of 90.29%. As a group, equities research analysts predict that Scancell Holdings plc will post -2.5361112 EPS for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage company leveraging two proprietary platforms, Immunobody® and Moditope®, to develop targeted off-the-shelf, patient-accessible active immunotherapies for a cancer-free future. The lead product iSCIB1+ is an Immunobody® DNA active immunotherapy that has demonstrated monotherapy activity in adjuvant melanoma. When combined with checkpoint therapies it showed additional clinical benefit over the checkpoints (CPI) alone in the ongoing Phase 2 SCOPE trial in advanced melanoma.